NDC 66992-208

ZONTIVITY

Vorapaxar

ZONTIVITY is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Wraser Pharmaceuticals, Llc. The primary component is Vorapaxar Sulfate.

Product ID66992-208_e946b6c2-23db-0d65-e053-2a95a90acd48
NDC66992-208
Product TypeHuman Prescription Drug
Proprietary NameZONTIVITY
Generic NameVorapaxar
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-09-21
Marketing CategoryNDA /
Application NumberNDA204886
Labeler NameWraSer Pharmaceuticals, LLC
Substance NameVORAPAXAR SULFATE
Active Ingredient Strength2 mg/1
Pharm ClassesProtease-activated Receptor-1 Antagonist [EPC], Protease-activated Receptor-1 Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 66992-208-30

30 TABLET, FILM COATED in 1 BOTTLE (66992-208-30)
Marketing Start Date2022-09-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ZONTIVITY" or generic name "Vorapaxar"

NDCBrand NameGeneric Name
66992-208ZONTIVITYvorapaxar
70347-208ZONTIVITYvorapaxar

Trademark Results [ZONTIVITY]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZONTIVITY
ZONTIVITY
86164928 not registered Dead/Abandoned
Merck Sharp & Dohme Corp.
2014-01-14
ZONTIVITY
ZONTIVITY
85307417 4628973 Live/Registered
ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
2011-04-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.